Literature DB >> 31867659

Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.

Micah L Berman1,2, Allison M Glasser1.   

Abstract

BACKGROUND: The US Food and Drug Administration (FDA) is considering reducing nicotine levels in cigarettes to "minimally or non-addictive levels." However, important research gaps remain, and the FDA must determine when the available research is sufficient to support moving forward.
METHODS: The authors conducted a systematic review of research articles in PubMed relating to nicotine reduction. Building on a review of risk assessment best practices, the authors also developed a risk assessment framework for tobacco regulation and used it to guide a gap analysis of nicotine reduction research.
RESULTS: The final sample consisted of 78 articles. The majority examined either nicotine dependence on very low nicotine cigarettes (VLNCs) or markers of potential health effects of using VLNCs. One-third of the identified articles reported results from four large randomized controlled trials (RCTs). While these studies report promising results and suggest that a nicotine reduction rule would be a powerful tool to reduce cigarette smoking, our gap analysis suggests that there is a need for studies that better reflect the use and availability of a wide range of tobacco/nicotine products and the potential for dual- or multi-product use.
CONCLUSION: The current body of research on nicotine reduction is weighted towards RCTs, which is appropriate for a policy that has not yet been implemented anywhere in the world. The FDA must consider a wide range of factors that may impact a product standard's public health impact, including those difficult to assess in RCTs, such as a nicotine reduction rule's impact on smoking initiation and relapse. IMPLICATIONS: This systematic review presents a gap analysis based on a risk assessment framework to help identify remaining research priorities to inform FDA's potential product standard to reduce nicotine levels in cigarettes. Quickly addressing those gaps would support the FDA's effort to develop a nicotine reduction product standard that will be effective and withstand legal challenges.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31867659      PMCID: PMC6939782          DOI: 10.1093/ntr/ntz162

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  96 in total

1.  Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Authors:  Eric C Donny; Rachel L Denlinger; Jennifer W Tidey; Joseph S Koopmeiners; Neal L Benowitz; Ryan G Vandrey; Mustafa al'Absi; Steven G Carmella; Paul M Cinciripini; Sarah S Dermody; David J Drobes; Stephen S Hecht; Joni Jensen; Tonya Lane; Chap T Le; F Joseph McClernon; Ivan D Montoya; Sharon E Murphy; Jason D Robinson; Maxine L Stitzer; Andrew A Strasser; Hilary Tindle; Dorothy K Hatsukami
Journal:  N Engl J Med       Date:  2015-10       Impact factor: 91.245

2.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Authors:  Stephen T Higgins; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Andrea C Villanti; John R Hughes; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Jeff S Priest; Joan M Skelly; Derek D Reed; Janice Y Bunn; Morgan A Tromblee; Christopher A Arger; Mollie E Miller
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

3.  Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.

Authors:  Jeffrey A Boatman; David M Vock; Joseph S Koopmeiners; Eric C Donny
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

4.  A ten fold reduction of nicotine yield in tobacco smoke does not spare the central cholinergic system in adolescent mice.

Authors:  Yael Abreu-Villaça; Monique Correa-Santos; Ana C Dutra-Tavares; Danielle Paes-Branco; Andre Nunes-Freitas; Alex C Manhães; Cláudio C Filgueiras; Anderson Ribeiro-Carvalho
Journal:  Int J Dev Neurosci       Date:  2016-06-07       Impact factor: 2.457

5.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

6.  Risk Assessment for Tobacco Regulation.

Authors:  Micah L Berman; Taleed El-Sabawi; Peter G Shields
Journal:  Tob Regul Sci       Date:  2019-01

7.  Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.

Authors:  Sarah S Dermody; F Joseph McClernon; Neal Benowitz; Xianghua Luo; Jennifer W Tidey; Tracy T Smith; Ryan Vandrey; Dorothy Hatsukami; Eric C Donny
Journal:  Exp Clin Psychopharmacol       Date:  2018-03-05       Impact factor: 3.157

8.  Efficiency and robustness of causal effect estimators when noncompliance is measured with error.

Authors:  Jeffrey A Boatman; David M Vock; Joseph S Koopmeiners
Journal:  Stat Med       Date:  2018-08-14       Impact factor: 2.373

9.  Examining Risk Perceptions Among Daily Smokers Naïve to Reduced Nicotine Content Cigarettes.

Authors:  Melissa Mercincavage; Kirsten Lochbuehler; Andrea C Villanti; E Paul Wileyto; Janet Audrain-McGovern; Andrew A Strasser
Journal:  Nicotine Tob Res       Date:  2019-06-21       Impact factor: 4.244

10.  Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes.

Authors:  Rachel L Denlinger; Tracy T Smith; Sharon E Murphy; Joseph S Koopmeiners; Neal L Benowitz; Dorothy K Hatsukami; Lauren R Pacek; Cirielle Colino; Samantha N Cwalina; Eric C Donny
Journal:  Tob Regul Sci       Date:  2016-04
View more
  12 in total

1.  The Public Health Gains Had Cigarette Companies Chosen to Sell Very Low Nicotine Cigarettes.

Authors:  David T Levy; K Michael Cummings; Bryan W Heckman; Yameng Li; Zhe Yuan; Tracy T Smith; Rafael Meza
Journal:  Nicotine Tob Res       Date:  2021-02-16       Impact factor: 4.244

2.  Blood Nicotine Predicts the Behavioral Economic Abuse Liability of Reduced-Nicotine Cigarettes.

Authors:  Brent A Kaplan; Elisa M Crill; Christopher T Franck; Warren K Bickel; Mikhail N Koffarnus
Journal:  Nicotine Tob Res       Date:  2022-03-26       Impact factor: 4.244

3.  Responses to reduced nicotine cigarette marketing features: a systematic review.

Authors:  Andrea C Johnson; Melissa Mercincavage; Valentina Souprountchouk; Sasha Rogelberg; Anupreet K Sidhu; Cristine D Delnevo; Andrew A Strasser
Journal:  Tob Control       Date:  2021-10-07       Impact factor: 7.552

4.  Educating the Public on the Health Risks of Very Low Nicotine Content Cigarettes: Results From a US-Based Convenience Sample.

Authors:  MacKenzie Differding; Sherri Jean Katz; Lori G Strayer; Cassidy White; Andrew A Strasser; Eric C Donny; Dorothy K Hatsukami; Dana Mowls Carroll
Journal:  Nicotine Tob Res       Date:  2022-04-28       Impact factor: 5.825

5.  Differences in acute reinforcement across reduced nicotine content cigarettes.

Authors:  Kenneth A Perkins; Joshua L Karelitz
Journal:  Psychopharmacology (Berl)       Date:  2020-03-27       Impact factor: 4.530

Review 6.  Reducing the relative value of cigarettes: Considerations for nicotine and non-nicotine factors.

Authors:  Cassidy M White; Dorothy K Hatsukami; Eric C Donny
Journal:  Neuropharmacology       Date:  2020-06-12       Impact factor: 5.250

7.  Impact of nicotine reduction in cigarettes on smoking behavior and exposure: Are there differences by race/ethnicity, educational attainment, or gender?

Authors:  Dana M Carroll; Bruce R Lindgren; Sarah S Dermody; Rachel Denlinger-Apte; Andrew Egbert; Rachel N Cassidy; Tracy T Smith; Lauren R Pacek; Alicia M Allen; Jennifer W Tidey; Michael J Parks; Joseph S Koopmeiners; Eric C Donny; Dorothy K Hatsukami
Journal:  Drug Alcohol Depend       Date:  2021-05-21       Impact factor: 4.852

8.  Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers.

Authors:  Maggie M Sweitzer; Lauren R Pacek; Rachel V Kozink; Erin Locey; Scott H Kollins; Eric C Donny; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2021-05-12       Impact factor: 4.415

9.  "I actually finally feel like the cigarettes aren't controlling me." - Interviews with participants smoking very low nicotine content cigarettes during a residential study.

Authors:  Rachel L Denlinger-Apte; Cassidy M White; Eric C Donny; Dorothy K Hatsukami; Neal L Benowitz; Matthew J Carpenter; Tracy T Smith
Journal:  Drug Alcohol Depend       Date:  2020-12-19       Impact factor: 4.492

10.  Nicotine Standards in the United States.

Authors:  Cassandra A Stanton; Dorothy K Hatsukami
Journal:  Nicotine Tob Res       Date:  2019-12-23       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.